scholarly article | Q13442814 |
P356 | DOI | 10.1038/SJ.CR.7310083 |
P698 | PubMed publication ID | 16826163 |
P2093 | author name string | Li Wang | |
Qi Cao | |||
Yan Zhang | |||
Jingwu Zhang | |||
Fang Du | |||
Baihua Shen | |||
Ningli Li | |||
Huiming Sheng | |||
Yingna Diao | |||
P2860 | cites work | Gadd45beta is important for perpetuating cognate and inflammatory signals in T cells | Q75202056 |
T-cell vaccination: from basics to the clinic | Q77152260 | ||
Suppressor of Cytokine Signaling-1 Is Essential for Suppressing Dendritic Cell Activation and Systemic Autoimmunity | Q79073423 | ||
Gadd45 beta mediates the protective effects of CD40 costimulation against Fas-induced apoptosis | Q28186473 | ||
IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production. | Q31929678 | ||
Cell death induced by the Fas/Fas ligand pathway and its role in pathology | Q33717488 | ||
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells | Q34147162 | ||
Linking JNK signaling to NF-kappaB: a key to survival | Q34358664 | ||
Functional avidity directs T-cell fate in autoreactive CD4+ T cells | Q35848366 | ||
Apoptosis, autophagy, and more | Q35869374 | ||
Gene-based vaccines and immunotherapeutics | Q35873176 | ||
Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation | Q35897221 | ||
Dominant tolerance: activation thresholds for peripheral generation of regulatory T cells | Q36061019 | ||
Fas (CD95)-related apoptosis and rheumatoid arthritis | Q36256257 | ||
Strategies of antigen-specific T-cell-based immunotherapy for cancer | Q36296600 | ||
Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis | Q36322609 | ||
Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo | Q36375248 | ||
FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. | Q36403535 | ||
Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen | Q36454472 | ||
GADD45beta/GADD45gamma and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNgamma production in T cells. | Q37544473 | ||
Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma | Q38287349 | ||
Prolongation of survival of rat cardiac allografts by T cell vaccination | Q40303030 | ||
NF-kappaB-dependent regulation of the timing of activation-induced cell death of T lymphocytes. | Q40321218 | ||
Turning on/off tumor-specific CTL response during progressive tumor growth | Q40382237 | ||
Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells | Q40395384 | ||
Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity | Q40488939 | ||
Escape from immune surveillance does not result in tolerance to tumor-associated antigens | Q40524777 | ||
Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways | Q40575783 | ||
Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination | Q40836907 | ||
Potent antitumour activity of a new class of tumour-specific killer cells | Q41135353 | ||
The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses | Q41870329 | ||
Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients | Q42065004 | ||
Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1. | Q42605307 | ||
Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo | Q42637071 | ||
Hematopoietic cells from Gadd45a- and Gadd45b-deficient mice are sensitized to genotoxic-stress-induced apoptosis | Q46709860 | ||
Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism | Q46740190 | ||
Immunocompetent cells and lymphocyte reactivity to mitogens in levamisole-treated brain tumor children | Q48161596 | ||
Interferon beta induces T-helper 2 immune deviation in MS | Q73187375 | ||
Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy | Q74627075 | ||
P433 | issue | 8 | |
P304 | page(s) | 702-712 | |
P577 | publication date | 2006-08-01 | |
P1433 | published in | Cell Research | Q1524018 |
P1476 | title | Immunization with autologous T cells enhances in vivo anti-tumor immune responses accompanied by up-regulation of GADD45beta | |
P478 | volume | 16 |